News

ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta® used in targeted radionuclide therapy.

Researchers studing E. coli report that most new genetic mutations that were passed on were beneficial and occurred at much more variable rates.

Researchers have discovered a gene that's linked to a rare, fatal syndrome in children has an important innate immunity role.

NIH mouse study identifies the mechanism responsible for a rare form of pediatric neuropathy.

The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.

Researchers have shown that obesity in mice has detrimental effect on influenza vaccine response.

Scientists have discovered that the microenvironment supporting cancer tumors starves immune cells of 'fuel', preventing tumour destruction.

Company has entered into an exclusive license agreement with MGH for advanced CRISPR genome editing technology.

Company announces milestone achieved for the progression of a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec.

Invio will continue to develop its heatitis B DNA immunotherapy independently after Roche discontinued its collaboration.